{"name":"Vallon Pharmaceuticals, Inc.","slug":"vallon-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE01QjdyZlhLMUhTcFNGUmR2VHYxQ29aZDNCR3BHZmlwQm5WWnJHNV8zcW12YzRLSjNiSUxTNDJ1ZG5LdWZQWHFNQi0yaWpDNFFza3Zj?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"VLON Stock Price, News & Analysis - Stock Titan","headline":"VLON Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNcUxHMmFPNHJZOThMZWNJc1hsNC1TOGVUaF9PTUpMd2NZelI3Y1FNWFYwYmY0b0F2bmhsRlpha1YxYkFTUm5JUUtkWGZrWW1adldySEgxVUg5OTM0dkJsSnpJbFBncWRKSkNDcUpLZ080T1pGT1FZSDNEM09KcUVzZGRiOGNWMy0zdy1wVlFnbEI2UTJG?oc=5","date":"2024-02-07","type":"trial","source":"Frontiers","summary":"Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials - Frontiers","headline":"Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQWHNuMmYyU0dYeFRna1RXMU02ck5fSklQZllyVFpBREZXNTRGOHJDejZGcGx4RzBFQzhXeDlpalAyOE8xWTlyTmZVUDAyZkhPV2xoNTZlRkRwOHBhUk14VnBOcEhQN3ZOaDdkb3lJZEdsaVRjWk9mS0tDRGU0VDRyQ0JYX0FlSHh5RjFaeWpab0hiNkwwZVk5NHhPNndOTGFPcWRpRjZJUllGVklqNEtZWnZGNVJidWJQbHA5SzYxRmJPT3JSdDZhZ0hKRjJFRmNUek9WUnU4R3NSOWt4bDhWTUI4RzB5WWYxXzRHa3RhbDU2a3UxY3RXYlBLbHNlLXU3bnNwazZEbS15MXFSdEVDaE5ZU0pfb0N2YXB0eWRTN0dQb3lzTTdaek5EMEFGaDVheng3ZFJkYw?oc=5","date":"2023-05-25","type":"trial","source":"PR Newswire","summary":"Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNMEd0UHBVWnVnNTRocjM3TXdHWmxBT3kxeXhaVjVHWlhXUkRtVjJ6S0N3U2FyendVMC0tQUoyUzBkdGVyUVRub0JLaEFJVk5ITHhXZjhXQmtqdVJFdEFTM1Vxbl83Z0lua0ljTzB4ZHJsVXFiWGJpNHAwTlZ2Ym5LbmNQQ19wbFBwMkk3d2t5U1dqeGhSOXRMNkhidW0tbUhwTDhIU3JwakJneGk0cVNZVlFiSjdoVGJ5ajJMeG9hdFVWcmctLXow?oc=5","date":"2023-04-21","type":"deal","source":"GlobeNewswire","summary":"Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc. - GlobeNewswire","headline":"Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPWVNQdURVV3FQbHo4UXVwd3R5dUtnNzMydnZZMDlzZEZnb2VzTDdTY2tIanZ3ZmtTRktYeWNuUnRxb2RqeFA5OWJpRmFSakJwWS1lY3hoZS1KZTRSNFlnbUFDOTM0VjBnYTBsZ1F5anc0YjZZYlpuS1RhQmNJZzdyR0YzU2l6eDVUYm02WnZfcnp4UFpzSEp1Nk1jSHo2bUxEb0NYRkVVQzhOclA1QTNNMEVMTnJPc1JlaFpKUmcycHhIMnRkM1FscDh1cE1RRVBtM1ZPX2lNbU1BRU1QcFB1T25KaVp6RWVkTnlGQVpBS2Y?oc=5","date":"2022-05-16","type":"earnings","source":"Investing.com UK","summary":"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More - Investing.com UK","headline":"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxORkpiMVNnRHZwdXdEcEkyd2tQVWN1NUtkM19OMTY1ZGtPSWJ1TFZIV2E0RXNMMnlMY0RFdjRHeld1MkJ4NkVUQTJ4dlpCRFVjcGNaaW9POExNb0FCbmk1YW1ESE51WEtxbXNkUHItd1hHdXpOZXVlZm5ndkhDMGxaY2xvQjZzRzA4TkVjcmhLaG5qV0prMUxNUWNSWQ?oc=5","date":"2022-04-22","type":"pipeline","source":"Yahoo Finance","summary":"Vallon Pharmaceuticals Announces Review of Strategic Alternatives - Yahoo Finance","headline":"Vallon Pharmaceuticals Announces Review of Strategic Alternatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNWFFwUlB4UDF5YTJ1a2doNlJEQVNfeUtVVFZUUGQ5UE9YTW9YUkhianhfTjVkbnRDVjRQZmFaY1Nua1N2Q3h0OUd4YWtVWFB4TmVKeEpIdFBjUVFLX2Z4THVzVm9EN0h0NzhlMVFnS1RRamJlcEQweDcxdDdINlZHc2NlOHhMeVFPNjR5emprRmJjQQ?oc=5","date":"2022-03-21","type":"trial","source":"BioSpace","summary":"Vallon’s Anti-Abuse ADHD Drug Formulation Flunks Clinical Trial - BioSpace","headline":"Vallon’s Anti-Abuse ADHD Drug Formulation Flunks Clinical Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}